The role of complement in the success of vaccination with conjugated vs. unconjugated polysaccharide antigen

Vaccine

Volumn 26, Issue 4, 2008, Pages 451-459

  Salehen, Nur'ain ^a   Stover, Cordula ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Complement; Polysaccharide; Vaccine

Indexed keywords

CARBOHYDRATE ANTIGEN; POLYSACCHARIDE ANTIGEN; POLYSACCHARIDE VACCINE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; COMPLEMENT SYSTEM; CONJUGATION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; PRIORITY JOURNAL; REVIEW; VACCINATION;

ANIMALS; ANTIGENS, BACTERIAL; B-LYMPHOCYTES; BACTERIAL INFECTIONS; BACTERIAL VACCINES; COMPLEMENT SYSTEM PROTEINS; HUMANS; IMMUNITY, ACTIVE; IMMUNITY, CELLULAR; MICE; POLYSACCHARIDES, BACTERIAL; SPLEEN; VACCINATION; VACCINES, CONJUGATE;

EID: 37849035900     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.11.049     Document Type: Review

References (91)

1. Du Pasquier L. The immune system of invertebrates and vertebrates. Comp Biochem Physiol 129 (2001) 1-15
2. Figdor C.G., van Kooyk Y., and Adema G. C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol 2 (2002) 77-84
3. Inohara N., and Nuñez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 3 (2003) 371-382
4. Schjetne K.W., Thompson K.M., Nilsen N., Flo T.H., Fleckenstein B., Iversen J.G., et al. Cutting edge: link between innate and adaptive immunity: Toll-like receptor 2 internalizes antigen for presentation to CD4+ T cells and could be an efficient vaccine target. Immunology 171 (2003) 32-36
5. Shakushiro K., Yamasaki Y., Nishikawa M., and Takakura Y. Efficient scavenger receptor-mediated uptake and cross-presentation of negatively charged soluble antigens by dendritic cells. Immunology 112 (2004) 211-218
6. Ruprecht C.R., and Lanzavecchia A. Toll-like receptor stimulation as a third signal required for activation of human naive B cells. Eur J Immunol 36 (2006) 810-816
7. Carroll M.C. The complement system in regulation of adaptive immunity. Nat Immunol 5 (2004) 981-986
8. Cherukuri A., Shoham T., Sohn H.W., Levy S., Brooks S., Carter R., et al. The tetraspanin CD81 is necessary for partitioning of coligated CD19/CD21-B cell antigen receptor complexes into signaling-active lipid rafts. J Immunol 172 (2004) 370-380
9. Lee C.J., Lee L.H., Lu C.S., and Wu A. Bacterial polysaccharides as vaccines-immunity and chemical characterization. Adv Exp Med Biol 491 (2001) 453-471
10. Arnaiz-Villena A., Jones B., and Roitt I.M. Allograft cytotoxicity. Role of T lymphocytes bearing a receptor for complement. Immunology 29 (1975) 903-908
11. Hammann K.P., Scheiner O., Schulz T., Erdei A., and Dierich M.P. Binding of the third component of complement (C3) to Thy-1.2 positive Con-A-induced blasts of the murine spleen: modulation of the C3 binding and cell aggregation by protease inhibitors. Immunology 48 (1983) 415-422
12. Fernandez-Centeno E., de Ojeda G., Rojo J.M., and Portoles P. Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells. J Immunol 164 (2000) 4533-4542
13. Steiniger B., Timphus E.M., and Barth P. The splenic marginal zone in humans and rodents: an enigmatic compartment and its inhabitants. Histochem Cell Biol 126 (2006) 641-648
14. Steiniger B., Barth P., Herbst B., Hartnell A., and Crocker P.R. The species-specific structure of microanatomical compartments in the human spleen: strongly sialoadhesin-positive macrophages occur in the perifollicular zone, but not in the marginal zone. Immunology 92 (1997) 307-316
15. Schmidt E.E., MacDonald I.C., and Groom A.C. Comparative aspects of splenic microcirculatory pathways in mammals: the region bordering the white pulp. Scan Microsc 7 (1993) 613-628
16. Mond J.J., Lees A., and Snapper C.M. T cell-independent antigens type 2. Ann Rev Immunol 13 (1995) 655-692
17. Viau M., and Zouali M. B-lymphocytes, innate immunity, and autoimmunity. Clin Immunol 114 (2005) 17-26
18. Ochsenbein A.F., and Zinkernagel R.M. Natural antibodies and complement link innate and acquired immunity. Immunol Today 21 (2000) 624-630
19. Timens W., Boes A., and Poppema S. Human marginal zone B cells are not an activated B cell subset: strong expression of CD21 as a putative mediator for rapid B cell activation. Eur J Immunol 19 (1989) 2163-2166
20. Brown S.L., Barrault D.V., Phythian-Adams A., and Knight A.M. Lack of induced co-stimulation as a result of complement receptor 2 (CR2) ligation on mouse splenic B cells. Int Immunol 18 1 (2006) 69-78
21. Rossbacher J., and Shlomchik M.J. The B cell receptor itself can activate complement to provide the complement receptor 1/2 ligand required to enhance B cell immune responses in vivo. J Exp Med 198 (2003) 591-602
22. Harris S., Finn A., and Granoff D. Disparity in functional activity between serum anticapsular antibodies induced in adults by immunization with an investigational group A and C Neisseria meningitidis-diphtheria toxoid conjugate vaccine and by a polysaccharide vaccine. Infect Immun 71 (2003) 3402-3408
23. Hu Y., and Test S.T. Functional differences in IgG anti-polysaccharide antibodies elicited by immunization of mice with C3d versus ovalbumin conjugates of pneumococcal serotype 14 capsular polysaccharide. Vaccine 23 (2004) 21-28
24. Lee C.J., Lee L.H., and Frasch C.E. Protective immunity of pneumococcal glycoconjugates. Crit Rev Microbiol 29 4 (2003) 333-349
25. Macallan D.C., Wallace D.L., Zhang Y., Ghattas H., Asquith B., de Lara C., et al. B-cell kinetics in humans: rapid turnover of peripheral blood memory cells. Blood 105 (2005) 3633-3640
26. Kelly D.F., Snape M.D., Cutterbuck E.A., Green S., Snowden C., Diggle L., et al. CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells. Blood 108 (2006) 2642-2647
27. Khan A., Lees A., and Snapper C. Differential regulation of IgG anti-capsular polysaccharide and antiprotein responses to intact Streptococcus pneumoniae in the presence of cognate CD4+ T cell help. J Immunol 172 (2004) 532-539
28. Obukhanych T., and Nussenzweig M. T-independent type II immune responses generate memory B cells. J Exp Med 203 (2006) 305-310
29. McCool T., Harding C., Greenspan N., and Schreiber J. B- and T-cell immune responses to pneumococcal conjugate vaccines: divergence between carrier- and polysaccharide-specific immunogenicity. Infect Immun 67 (1999) 4862-4869
30. Phan T., Gardam S., Basten A., and Brink R. Altered migration, recruitment, and somatic hypermutation in the early response of marginal zone B cells to T cell-dependent antigen. J Immunol 174 (2005) 4567-4578
31. Martin F., and Kearney J.F. Marginal-zone B cells. Nat Rev Immunol 2 (2002) 323-335
32. Delemarre F.G., Claassen E., and Van Rooijen N. Primary in situ immune response in popliteal lymph nodes and spleen of mice after subcutaneous immunization with thymus-dependent or thymus-independent (type 1 and 2) antigens. Anat Rec 223 (1989) 152-157
33. Lentz V., and Manser T. Germinal centers can be induced in the absence of T cells. J Immunol 167 (2001) 15-20
34. Willenbrock K., Jungnickel B., Hansmann M.L., and Küppers R. Human splenic marginal zone B cells lack expression of activation-induced cytidine deaminase. Eur J Immunol 35 (2005) 3002-3007
35. Wu Z.Q., Khan A., Shen Y., Schartman J., Peach R., Lees A., et al. B7 requirements for primary and secondary protein- and polysaccharide-specific Ig isotype responses to Streptococcus pneumoniae. J Immunol 165 (2000) 6840-6848
36. Gray D., McConnell I., Kumararatne D.S., MacLennan I.C., Humphrey J.H., and Bazin H. Marginal zone B cells express CR1 and CR2 receptors. Eur J Immunol 14 (1984) 47-52
37. Karlsson M., Guinamard R., Bolland S., Sankala M., Steinman R., and Ravetch J. Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J Exp Med 198 (2003) 333-340
38. Fischer M.B., Ma M., Hsu N.C., and Carroll M.C. Local synthesis of C3 within the splenic lymphoid compartment can reconstitute the impaired immune response in C3-deficient mice. J Immunol 160 (1998) 2619-2625
39. Geijtembeck T., Groot P., Nolte M., van Vliet S., Gangaram-Panday S., van Duijnhoven G., et al. Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo. Blood 100 (2002) 2908-2916
40. Chen Y., Pikkarainen T., Elomaa O., Soininen R., Kodama T., Kraal G., et al. Defective microarchitecture of the spleen marginal zone and impaired response to a thymus-independent type 2 antigen in mice lacking scavenger receptors MARCO and SR-A. J Immunol 175 (2005) 8173-8180
41. Reynes M., Aubert J.P., Cohen J., Audouin J., Tricottet V., Diebold J., et al. Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens. J Immunol 135 (1985) 2687-2694
42. Schwaeble W., Schafer M.K., Petry F., Fink T., Knebel D., Weihe E., et al. Follicular dendritic cells, interdigitating cells, and cells of the monocyte-macrophage lineage are the C1q-producing sources in the spleen. Identification of specific cell types by in situ hybridization and immunohistochemical analysis. J Immunol 155 (1995) 4971-4978
43. Vinci G., Lynch N.J., Duponchel C., Lebastard T.M., Milon G., Stover C., et al. In vivo biosynthesis of endogenous and of human C1 inhibitor in transgenic mice: tissue distribution and colocalization of their expression. J Immunol 169 (2002) 5948-5954
44. Fang Y., Xu C., Fu Y.-X., Holers V.M., and Molina H. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J Immunol 160 (1998) 5273-5279
45. Zwirner J., Felber E., Schmidt P., Rietmuller G., and Feucht H.E. Complement activation in human lymphoid germinal centres. Immunology 66 (1998) 270-277
46. Stover C. Structural and functional biology of MASP-2, the third component of the novel antibody independent lectin route of complement activation. PhD Thesis. University of Leicester; 1999.
47. Maves K.K., and Weiler J.M. Detection of properdin mRNA in human peripheral blood monocytes and spleen. J Lab Clin Med 120 (1992) 762-766
48. Reis E., Falcao D.A., and Isaac L. Clinical aspects and molecular basis of primary deficiencies of complement component C3 and its regulatory proteins factor I and factor H. Scand J Immunol 63 (2006) 155-168
49. Volanakis J.E. Complement-induced solubilization of C-reactive protein-pneumococcal C-polysaccharide precipitates: evidence for covalent binding of complement proteins to C-reactive protein and to pneumococcal C-polysaccharide. J Immunol 128 (1982) 2745-2750
50. Winkelstein J.A., Bocchini Jr. J.A., and Schiffman G. The role of the capsular polysaccharide in the activation of the alternative pathway by the pneumococcus. J Immunol 116 (1976) 367-370
51. Kang Y.-S., Do Y., Lee H.-K., Park S., Cheong C., Lynch R., et al. A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q. Cell 125 (2006) 47-58
52. Harms G., Hardonk M.J., and Timens W. In vitro complement-dependent binding and in vivo kinetics of pneumococcal polysaccharide TI-2 antigens in the rat spleen marginal zone and follicle. Infect Immun 64 (1996) 4220-4225
53. Breukels M.A., Zandvoort A., Rijkers G.T., Lodewijk M.E., Klok P.A., Harms G., et al. Complement dependency of splenic localization of pneumococcal polysaccharide and conjugate vaccines. Scand J Immunol 61 (2005) 322-328
54. Peset Llopis M.J., Harms G., Hardonk M.J., and Timens W. Human immune response to pneumococcal polysaccharides: complement-mediated localization preferentially on CD21-positive splenic marginal zone B cells and follicular dendritic cells. J Allergy Clin Immunol 97 (1996) 1015-1024
55. Schwendinger M., Spruth M., Schoch J., Dierich M., and Prodinger W. A novel mechanism of alternative pathway complement activation accounts for the deposition of C3 fragments on CR2-expressing homologous cells. J Immunol 158 (1997) 5455-5463
56. Molina H., Holers V.M., Li B., Fung Y., Mariathasan S., Goellner J., et al. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci USA 93 (1996) 3357-3361
57. Ahearn J.M., Fischer M.B., Croix D., Goerg S., Ma M., Xia J., et al. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4 (1996) 251-262
58. Cutler A.J., Botto M., van Essen D., Rivi R., Davies K.A., Gray D., et al. T cell-dependent immune response in C1q-deficient mice: defective interferon gamma production by antigen-specific T cells. J Exp Med 187 (1998) 1789-1797
59. Fischer M., Ma M., Goerg S., Zhou X., Xia J., Finco O., et al. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol 157 (1996) 549-556
60. Yalcindag A., He R., Laouini D., Alenius H., Carroll M., Oettgen H.C., et al. The complement component C3 plays a critical role in both Th1 and Th2 responses to antigen. J Allergy Clin Immunol 117 (2006) 1455-1461
61. Matsumoto M., Fukuda W., Circolo A., Goellner J., Strauss-Schoenberger J., Wang X., et al. Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc Natl Acad Sci USA 94 (1997) 8720-8725
62. Breukels M.A., Zandvoort A., van Den Dobbelsteen G.P., van Den Muijsenberg A., Lodewijk M.E., Beurret M., et al. Pneumococcal conjugate vaccines overcome splenic dependency of antibody response to pneumococcal polysaccharides. Infect Immun 69 (2001) 7583-7587
63. Weller S., Reynaud C.A., and Weill J.C. Vaccination against encapsulated bacteria in humans: paradoxes. Trends Immunol 26 (2005) 85-89
64. Ross S.C., and Densen P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore) 63 (1984) 243-273
65. Fijen C.A., Kuijper E.J., Drogari-Apiranthitou M., Van Leeuwen Y., Daha M.R., and Dankert J. Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine. Clin Exp Immunol 114 (1998) 362-369
66. Soderstrom C., Braconier J.H., Kayhty H., Sjoholm A.G., and Thuresson B. Immune response to tetravalent meningococcal vaccine: opsonic and bactericidal functions of normal and properdin deficient sera. Eur J Clin Microbiol Infect Dis 8 (1989) 220-224
67. Densen P., Weiler J., Griffiss J., and Hoffmann L. Familial properdin deficiency and fatal meningococcemia. Correction of the bactericidal defect by vaccination. N Engl J Med 316 (1987) 922-926
68. Spath P.J., Sjoholm A.G., Fredrikson G.N., Misiano G., Scherz R., Schaad U.B., et al. Properdin deficiency in a large Swiss family: identification of a stop codon in the properdin gene, and association of meningococcal disease with lack of the IgG2 allotype marker G2m(n). Clin Exp Immunol 118 (1999) 278-284
69. Griffioen A.W., Rijkers G.T., Janssens-Korpela P., and Zegers B.J. Pneumococcal polysaccharides complexed with C3d bind to human B lymphocytes via complement receptor type 2. Infect Immun 59 (1991) 1839-1845
70. Hazlewood M.A., Kumararatne D.S., Webster A.D., Goodall M., Bird P., and Daha M. An association between homozygous C3 deficiency and low levels of anti-pneumococcal capsular polysaccharide antibodies. Clin Exp Immunol 87 (1992) 404-409
71. Pihlgren M., Fulurija A., Villiers M.-B., Tougne C., Lambert P.H., Villiers C.L., et al. Influence of complement C3 amount on IgG responses in early life: immunization with C3b-conjugated antigen increases murine neonatal antibody responses. Vaccine 23 (2004) 329-335
72. Pihlgren M., Tougne C., Bozzotti P., Fulurija A., Duchosal M.A., Lambert P.H., et al. Unresponsiveness to lymphoid-mediated signals at the neonatal follicular dendritic cell precursor level contributes to delayed germinal center induction and limitations of neonatal antibody responses to T-dependent antigens. J Immunol 170 (2003) 2824-2832
73. Oliver A.M., Martin F., and Kearney J.F. IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J Immunol 162 (1999) 7198-7207
74. Zandvoort A., and Timens W. The dual function of the splenic marginal zone: essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens. Clin Exp Immunol 130 (2002) 4-11
75. Attanavanich K., and Kearney J. Marginal zone, but not follicular B cells, are potent activators of naïve CD4 T cells. J Immunol 172 (2004) 803-811
76. Pillai S., Cariappa A., and Moran S. Marginal zone B cells. Annu Rev Immunol 23 (2005) 161-196
77. Zandvoort A., Lodewijk M.E., de Boer N.K., Dammers P.M., Kroese F.G., and Timens W. CD27 expression in the human splenic marginal zone: the infant marginal zone is populated by naïve B cells. Tissue Antigens 58 (2001) 234-242
78. Kruetzmann S., Rosado M.M., Weber H., Germing U., Tournilhac O., Peter H.H., et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 197 (2003) 939-945
79. Adderson E. Antibody repertoires in infants and adults: effects of T-independent and T-dependent immunizations. Springer Semin Immunopathol 23 (2001) 387-403
80. Jakobsen H., Hannesdottir S., Bjarnarson S.P., Schulz D., Trannoy E., Siegrist C.A., et al. Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharide-specific antibody response and protective efficacy. Eur J Immunol 36 (2006) 287-295
81. Powers D.C., Anderson E.L., Lottenbach K., and Mink C.M. Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults. J Infect Dis 173 (1996) 1014-1018
82. Lottenbach K., Mink C., Barenkamp S., Anderson E., Homan S., and Powers D. Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination. Infect Immun 67 (1999) 4935-4938
83. Werre J.M., and de Haan L.D. Pneumococcal polysaccharide vaccines. Neth J Med 62 (2004) 33-35
84. Vinuesa C.G., de Lucas C., and Cook M.C. Clinical implications of the specialised B cell response to polysaccharide encapsulated pathogens. Postgrad Med J 77 (2001) 562-569
85. Mebius R.E., and Kraal G. Structure and function of the spleen. Nat Rev Immunol 5 (2005) 606-616
86. Martin F., Oliver A.M., and Kearney J.F. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14 (2001) 617-629
87. Coil J.A., Dickerman J., Horner S.R., and Chalmer B.J. Pulmonary infection in splenectomized mice: protection by splenic remnant. J Surg Res 28 (1980) 18-22
88. Guinamard R., Okigaki M., Schlessinger J., and Ravetch J. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat Immunol 1 (2000) 31-36
89. Ferguson A.R., Youd M.E., and Corley R.B. Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells. Int Immunol 16 10 (2004) 1411-1422
90. Rickert R.C. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex. Curr Opin Immunol 17 (2005) 237-243
91. Leemans R., Harms G., Rijkers G., and Timens W. Spleen autotransplantation provides restoration of functional splenic lymphoid compartments and improves the humoral immune response to pneumococcal polysaccharide vaccine. Clin Exp Immunol 117 (1999) 596-604